Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy, safety, and survival factors for sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma.
Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Sakata K, Matsugaki S, Kajiwara M, Fukuizumi K, Tajiri N, Matsukuma N, Sakai T, Ono N, Yano Y, Koga H, Kurogi J, Takata A, Sumie S, Satani M, Yamada S, Niizeki T, Aino H, Iwamoto H, Torimura T, Sata M. Nakano M, et al. Among authors: yamada s. Oncology. 2013;84(2):108-14. doi: 10.1159/000342650. Epub 2012 Nov 9. Oncology. 2013. PMID: 23147476
Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study.
Sumie S, Kawaguchi T, Kawaguchi A, Kuromatsu R, Nakano M, Satani M, Yamada S, Okamura S, Yonezawa Y, Kakuma T, Torimura T, Sata M. Sumie S, et al. Among authors: yamada s. Mol Clin Oncol. 2015 Jan;3(1):115-120. doi: 10.3892/mco.2014.435. Epub 2014 Oct 6. Mol Clin Oncol. 2015. PMID: 25469280 Free PMC article.
Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: a new biomarker for overall survival of patients with malignant diseases.
Matsueda S, Komatsu N, Kusumoto K, Koga S, Yamada A, Kuromatsu R, Yamada S, Seki R, Yutani S, Shichijo S, Mine T, Fukuda T, Okamura T, Okuda S, Sata M, Honda J, Kaji M, Itoh K, Sasada T. Matsueda S, et al. Among authors: yamada a, yamada s. Dev Comp Immunol. 2013 Sep;41(1):68-76. doi: 10.1016/j.dci.2013.04.004. Epub 2013 Apr 11. Dev Comp Immunol. 2013. PMID: 23583523
Roles of high-mobility group box 1 in murine experimental colitis.
Yamasaki H, Mitsuyama K, Masuda J, Kuwaki K, Takedatsu H, Sugiyama G, Yamada S, Sata M. Yamasaki H, et al. Among authors: yamada s. Mol Med Rep. 2009 Jan-Feb;2(1):23-7. doi: 10.3892/mmr_00000056. Mol Med Rep. 2009. PMID: 21475785
8,524 results